EndometriosisNCT07472842
Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis
A study testing Emergency care for endometriosis in people with Endometriosis and Pelvic Pain Syndrome, run by Centre Hospitalier Intercommunal Creteil at 1 site in France.
Trial summary
Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Endometriosis, Pelvic Pain Syndrome, Chronic Gynaecological Disease
- What is being tested?
- Emergency care for endometriosis
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteFrance
- Study dates
- 16 Oct 2025to 15 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patient (aged 18 or over)
- Patient consulting the gynecological emergency department at Créteil Hospital for
- Known endometriosis or
- Symptoms suggestive of endometriosis: dysmenorrhea, pelvic pain, cyclic dysuria, dyspareunia, cyclic dyschezia, infertility, rectal bleeding, chest pain, catamenial hematuria
- Patient who speaks French and is able to understand the information sheet
Who cannot join
- Minor or menopausal patient
- Pregnant and breastfeeding patient
- Other reason for consultation
- Patient refusal
- Patient not affiliated with a social security system
- Patient cannot be contacted for the 3-months questionnaire
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
CHI Créteil
Créteil, 94000
Yann SAHLI, MD, 01 57 02 20 00, yann.sahli@chicreteil.fr
About this study
Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis
Read the detailed description
Endometriosis is defined as the presence outside the uterine cavity of tissue similar to the uterine mucosa, which will be affected by hormonal changes during each subsequent menstrual cycle. Endometriosis is thus responsible for pelvic pain, which can be particularly incapacitating, as well as other symptoms depending on the location of the lesions. In some cases, endometriosis is also responsible for infertility. Symptoms have a considerable impact on the quality of life of sufferers, affecting not only their personal and marital lives, but also their professional and social lives.
- Being tested
- Emergency care for endometriosis
- Keywords
- infertility, dysmenorrhea, pelvic pain
- Medical subject headings
- Endometriosis, Infertility, Dysmenorrhea, Pelvic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Emergency care for endometriosisDiagnostic test
Emergency care for endometriosis
- Introduction of specific treatment for endometriosis
- Scheduled or completed specialist consultation (gynecologist, surgeon, midwife, radiologist)
- Pelvic imaging examination scheduled or completed since the gynecological emergency consultation
| Study group | Role | What they receive |
|---|---|---|
| Impact of emergency room care on endometriosis or its diagnosis | Other | Not described Receives: Diagnostic Test: Emergency care for endometriosis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis
Composite criteria : number of specific hormonal or analgesic treatment introduiced for endometriosis according to ESHRE guideline endometriosis
Measured: At 3 months
Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis
Composite criteria : number of scheduled or completed specialist consultation (gynaecologist, surgeon, midwife, radiologist)
Measured: At 3 months
Assessing the impact of treatment in gynecological emergency departments on patients endometriosis or suspected endometriosis
Composite criteria : number of Pelvic imaging recommanded for diagnostic or follow up of endometriosis, according to ESHRE guideline, scheduled or completed since the gynecological emergency consultation
Measured: At 3 months
Assessing the impact of deprivation on the future of patients after consultation at gynaecological emergency departments.
EPICE Scores (Evaluation of Deprivation and Inequalities in Health Examination Centers)
Measured: At 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Mar 2026
- Study start16 Oct 2025
- Primary completion15 Jan 2026
- Study completion15 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EndometriosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07472842
- Sponsor's protocol ID
- ENDO URG
- Status last verified
- Aug 2026
- First submitted
- 25 Aug 2025
- Last updated
- 26 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis
- ClinicalTrials.gov ID
- NCT07472842
- Acronym / sponsor ID
- ENDO URG
- Keywords
- infertility, dysmenorrhea, pelvic pain
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Centre Hospitalier Intercommunal CreteilUniversity, hospital or other
- Study start
- 16 Oct 2025 (actual)
- Primary completion
- 15 Jan 2026 (actual)
- Study completion
- 15 Nov 2026 (estimated)
- First posted
- 16 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis
Detailed description
Endometriosis is defined as the presence outside the uterine cavity of tissue similar to the uterine mucosa, which will be affected by hormonal changes during each subsequent menstrual cycle. Endometriosis is thus responsible for pelvic pain, which can be particularly incapacitating, as well as other symptoms depending on the location of the lesions. In some cases, endometriosis is also responsible for infertility. Symptoms have a considerable impact on the quality of life of sufferers, affecting not only their personal and marital lives, but also their professional and social lives.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Impact of emergency room care on endometriosis or its diagnosis | Other | Diagnostic Test: Emergency care for endometriosis |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adult patient (aged 18 or over)
- Patient consulting the gynecological emergency department at Créteil Hospital for
- Known endometriosis or
- Symptoms suggestive of endometriosis: dysmenorrhea, pelvic pain, cyclic dysuria, dyspareunia, cyclic dyschezia, infertility, rectal bleeding, chest pain, catamenial hematuria
- Patient who speaks French and is able to understand the information sheet
Key exclusion criteria (6 listed)
- Minor or menopausal patient
- Pregnant and breastfeeding patient
- Other reason for consultation
- Patient refusal
- Patient not affiliated with a social security system
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Emergency care for endometriosisEmergency care for endometriosis * Introduction of specific treatment for endometriosis * Scheduled or completed specialist consultation (gynecologist, surgeon, midwife, radiologist) * Pelvic imaging examination scheduled or completed since the gynecological emergency consultation | Diagnostic test | Impact of emergency room care on endometriosis or its diagnosis |
Primary outcome
Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis
Time frame: At 3 months
Composite criteria : number of specific hormonal or analgesic treatment introduiced for endometriosis according to ESHRE guideline endometriosis
Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis
Time frame: At 3 months
Composite criteria : number of scheduled or completed specialist consultation (gynaecologist, surgeon, midwife, radiologist)
Assessing the impact of treatment in gynecological emergency departments on patients endometriosis or suspected endometriosis
Time frame: At 3 months
Composite criteria : number of Pelvic imaging recommanded for diagnostic or follow up of endometriosis, according to ESHRE guideline, scheduled or completed since the gynecological emergency consultation
Assessing the impact of deprivation on the future of patients after consultation at gynaecological emergency departments.
Time frame: At 3 months
EPICE Scores (Evaluation of Deprivation and Inequalities in Health Examination Centers)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Aug 2026.
Related trials for Endometriosis
Not yet recruiting
Prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in Women With Endometriosis
SIBO, Endometriosis
Recruiting
Endometriosis Transcriptomic Cell Atlas
Endometriosis, Infertility
Not yet recruiting
Psychotherapy in Patients With Endometriosis: Cognitive Behavioral Therapy Versus Acceptance and Commitment Therapy
Endometriosis, Adenomyosis
Not yet recruitingObservational study
Impact of a Diagnosis or Lack of a Diagnosis of Endometriosis Via a Saliva Test on Pain Catastrophizing, Quality of Life, Symptoms of Anxiety and Depression, and Treatment Adherence
Endometriosis
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Emergency care for endometriosis in people with Endometriosis and Pelvic Pain Syndrome, run by Centre Hospitalier Intercommunal Creteil at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yann SALHI, MD (01 57 02 20 00 ext. 8456, yann.salhi@chicreteil.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessing the impact of treatment in gynecological emergency departments on patients with endometriosis or suspected endometriosis (time frame: At 3 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.